Concord Biotech to Procure Wind-Solar Power from CleanMax’s Project
The pharmaceutical company acquired a 26% stake in CleanMax Everglades
January 17, 2025
Follow Mercom India on WhatsApp for exclusive updates on clean energy news and insights
Ahmedabad-based pharmaceutical company Concord Biotech has entered into a strategic agreement to acquire a 26% equity stake in CleanMax Everglades, a CleanMax Enviro Energy Solutions special purpose vehicle that is setting up a renewable energy project with a total capacity of 9.9 MW.
